GMP-compliant automated radiosynthesis of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A)

2024-9-10

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?

2024-9-5

DESI-TQ-MS imaging for ex vivo brain biodistribution assessment: evaluation of LBT-999, a ligand of the dopamine transporter (DAT)

2024-8-27

Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer

2024-8-24

Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma

2024-8-20

Scalability study on [133La]LaCl3 production with a focus on potential clinical applications

2024-8-15

109Pd/109mAg in-vivo generator in the form of nanoparticles for combined β- - Auger electron therapy of hepatocellular carcinoma

2024-8-13

Development of caspase-3-selective activity-based probes for PET imaging of apoptosis

2024-8-8

Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging

2024-8-2

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

2024-7-31

In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions

2024-7-29

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer

2024-7-24

Process validation and preclinical development of a new PET cerebral blood flow tracer [11C]MMP for initial clinical trials

2024-7-23

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma

2024-7-15

cGMP compliant one-step, one-pot automated [18F]FBnTP production for clinical imaging of mitochondrial activity

2024-6-27

Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method

2024-6-21

Recently developed radiopharmaceuticals for bacterial infection imaging

2024-6-19

In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure

2024-6-17

Trans-cyclooctene—a Swiss army knife for bioorthogonal chemistry: exploring the synthesis, reactivity, and applications in biomedical breakthroughs

2024-6-6

Synthesis and evaluation of [18F]FBNAF, a STAT3-targeting probe, for PET imaging of tumor microenvironment

2024-6-4

Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [18F]FSW-100 for clinical applications

2024-6-3

eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors

2024-5-22

In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211

2024-5-22

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

2024-5-16

[68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserve

2024-5-15

Good practices for 89Zr radiopharmaceutical production and quality control

2024-5-11

Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE

2024-5-8

Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications

2024-5-6

Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape

2024-5-4

99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications

2024-5-2

GMP production of [18F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport

2024-5-2

Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates

2024-4-29

Small animal PET imaging with the 68Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model

2024-4-27

Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model

2024-4-18

Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators

2024-4-17

Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation

2024-4-16

Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial

2024-4-15

Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects

2024-4-2

Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)

2024-4-2

In vivo evaluation of tumor uptake and bio-distribution of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in mice model

2024-3-29

Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections

2024-3-26

In-target production of [11C]CH4 from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperature

2024-3-25

Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals

2024-3-21

Correction: Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding

2024-3-19

Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET

2024-3-6

Preclinical characterisation of gallium-68 labeled ferrichrome siderophore stereoisomers for PET imaging applications

2024-3-4

A novel PET probe to selectively image heat shock protein 90α/β isoforms in the brain

2024-3-4

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

2024-2-26

Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics

2024-2-26

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

2024-2-23